Woodstock

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Obesity4 trials
• Type 2 diabetes3 trials
• Heart failure1 trial
• Type 1 diabetes1 trial

Phase

• Phase 34 trials
• Phase 21 trial

Status

• Recruiting4 trials
• Completed1 trial

Lead sponsor

• AstraZeneca5 trials

Running trials

• Recruiting

  A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

  NCT07776509· Phase 3· AstraZeneca· Source

• Recruiting

  A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  NCT07784270· Phase 3· AstraZeneca· Source

• Recruiting

  A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

  NCT07667803· Phase 3· AstraZeneca· Source

• Recruiting

  Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

  NCT06677060· Phase 3· AstraZeneca· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity3 recruiting
• Type 2 diabetes3 recruiting
• Heart failure1 recruiting
• Type 1 diabetes1 recruiting

Closed trials

• Completed

  A Study in Participants With Obesity or Overweight With at Least One Weight-related Comorbidity

  NCT06595238· Phase 2· AstraZeneca· Source